Publications list | EBMT

Top

Area

Group

Year

Disease

Text

The 2023 EBMT report on hematopoietic cell transplantation and cellular therapies. Increased use of allogeneic HCT for myeloid malignancies and of CAR-T at the expense of autologous HCT

Acute Leukemia Working Party (ALWP)

Severe Aplastic Anaemia Working Party (SAAWP)

Autoimmune Diseases Working Party (ADWP)

Chronic Malignancies Working Party (CMWP)

Cellular Therapy & Immunobiology Working Party (CTIWP)

Inborn Errors Working Party (IEWP)

Infectious Diseases Working Party (IDWP)

Transplant Complications Working Party (TCWP)

Lymphoma Working Party (LWP)

Paediatric Diseases Working Party (PDWP)

Haemoglobinopathies Working Party (HWP)

Activity survey office

1st listed author

Jakob R Passweg

Bone Marrow Transplant.

Hematopoietic cell transplantation and cellular therapies in Europe 2022. CAR-T activity continues to grow; transplant activity has slowed: a report from the EBMT

Acute Leukemia Working Party (ALWP)

Severe Aplastic Anaemia Working Party (SAAWP)

Autoimmune Diseases Working Party (ADWP)

Chronic Malignancies Working Party (CMWP)

Cellular Therapy & Immunobiology Working Party (CTIWP)

Inborn Errors Working Party (IEWP)

Infectious Diseases Working Party (IDWP)

Transplant Complications Working Party (TCWP)

Lymphoma Working Party (LWP)

Paediatric Diseases Working Party (PDWP)

Haemoglobinopathies Working Party (HWP)

Activity survey office

1st listed author

Jakob R. Passweg

Bone Marrow Transplant.

Hematopoietic cell transplantation and cellular therapies in Europe 2021. The second year of the SARS-CoV-2 pandemic. A Report from the EBMT Activity Survey

Acute Leukemia Working Party (ALWP)

Severe Aplastic Anaemia Working Party (SAAWP)

Autoimmune Diseases Working Party (ADWP)

Chronic Malignancies Working Party (CMWP)

Cellular Therapy & Immunobiology Working Party (CTIWP)

Inborn Errors Working Party (IEWP)

Infectious Diseases Working Party (IDWP)

Transplant Complications Working Party (TCWP)

Lymphoma Working Party (LWP)

Paediatric Diseases Working Party (PDWP)

Haemoglobinopathies Working Party (HWP)

Activity survey office

1st listed author

Jakob R Passweg

Bone Marrow Transplant.

Impact of the SARS-CoV-2 pandemic on hematopoietic cell transplantation and cellular therapies in Europe 2020: a report from the EBMT activity survey

Activity survey office

1st listed author

Jakob R Passweg

Bone Marrow Transplant.

Hematopoietic cell transplantation and cellular therapy survey of the EBMT: monitoring of activities and trends over 30 years

Activity survey office

1st listed author

Jakob R. Passweg

Bone Marrow Transplant.

The EBMT activity survey on hematopoietic-cell transplantation and cellular therapy 2018: CAR-T's come into focus.

Activity survey office

1st listed author

Bone Marrow Transplant.

The EBMT activity survey report 2017: a focus on allogeneic HCT for nonmalignant indications and on the use of non-HCT cell therapies.

Activity survey office

1st listed author

Bone Marrow Transplant.

Is the use of unrelated donor transplantation leveling off in Europe? The 2016 European Society for Blood and Marrow Transplant activity survey report

Activity survey office

1st listed author

Bone Marrow Transplant.

Use of haploidentical stem cell transplantation continues to increase: the 2015 European Society for Blood and Marrow Transplant activity survey report.

Activity survey office

1st listed author

Bone Marrow Transplant.

Hematopoietic stem cell transplantation in Europe 2014: more than 40‚000 transplants annually.

Activity survey office

1st listed author

Bone Marrow Transplant.

Hematopoietic SCT in Europe 2013: recent trends in the use of alternative donors showing more haploidentical donors but fewer cord blood transplants.

Activity survey office

1st listed author

Bone Marrow Transplant.

Hematopoietic SCT in Europe: data and trends in 2012 with special consideration of pediatric transplantation.

Activity survey office

1st listed author

Bone Marrow Transplant.